Wells Fargo & Company MN Buys 5,594 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Wells Fargo & Company MN boosted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 4.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 124,940 shares of the company’s stock after buying an additional 5,594 shares during the period. Wells Fargo & Company MN owned about 0.14% of HealthEquity worth $11,988,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in HQY. Wealthfront Advisers LLC acquired a new position in HealthEquity in the fourth quarter worth $10,304,089,000. Norges Bank acquired a new stake in shares of HealthEquity in the 4th quarter valued at approximately $74,701,000. Raymond James Financial Inc. acquired a new stake in HealthEquity in the fourth quarter worth $45,728,000. Artisan Partners Limited Partnership bought a new position in HealthEquity during the fourth quarter worth about $24,568,000. Finally, Geneva Capital Management LLC increased its stake in HealthEquity by 24.6% during the 4th quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock worth $100,642,000 after purchasing an additional 206,894 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insider Activity at HealthEquity

In related news, EVP Michael Henry Fiore sold 8,881 shares of the firm’s stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares of the company’s stock, valued at approximately $4,433,820.30. This trade represents a 13.55 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 20,381 shares of company stock worth $1,781,432. Insiders own 2.20% of the company’s stock.

HealthEquity Trading Down 0.4 %

HQY stock opened at $83.03 on Wednesday. The stock has a market cap of $7.18 billion, a price-to-earnings ratio of 76.17, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. The company has a fifty day moving average price of $96.47 and a two-hundred day moving average price of $96.35. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

Wall Street Analysts Forecast Growth

HQY has been the topic of several recent research reports. Barrington Research reissued an “outperform” rating and issued a $112.00 price target on shares of HealthEquity in a research note on Friday, April 11th. The Goldman Sachs Group decreased their price target on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research note on Thursday, March 27th. Raymond James upgraded shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and reduced their target price for the stock from $120.00 to $115.00 in a report on Tuesday, March 25th. Wells Fargo & Company raised their price target on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Finally, KeyCorp dropped their price objective on HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Monday, March 24th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and an average target price of $112.58.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.